期刊文献+

肝脏疾病诊断治疗中实验室检测项目的应用建议 被引量:17

原文传递
导出
摘要 为了在肝脏疾病的诊断和治疗中科学、合理地应用实验室检测项目,中华医学会检验分会、卫生部临床检验中心和中华检验医学杂志编辑委员会共同决定制定肝脏疾病诊断治疗中实验室检测项目的应用建议,并委托中华医学会检验分会的《临床疾病实验室检测项目应用建议》编写组负责起草制定。本应用建议在制定过程中,通过多种方式广泛征求临床肝脏疾病学专家和检验医学工作者的意见,作为修改的一个重要参考依据。
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2013年第9期773-784,共12页 Chinese Journal of Laboratory Medicine
基金 卫生部国家临床重点专科建设项目资助项目 "十二五"国家科技支撑计划课题资助项目(2012BAI37801)
  • 相关文献

参考文献68

  • 1Dufour DR, Lott JA, Nolte FS, et al. Diagnosis and monitoring ofhepatic injury. I. Performance characteristics of laboratory tests.Clin Chem, 2000,46:2027-2049.
  • 2Thomas L,Whicher JT, Andert SE. Clinical laboratorydiagnostics : use and assessment of clinical laboratory results.Frankfurt : TH-Books Verlagsgesellschaft, 1998.
  • 3Ceriotti F, Henny J, Queralto J,et al. Common referenceintervals for aspartate aminotransferase ( AST ), alanineaminotransferase ( ALT) and ^-glutamyl transferase ( GGT) inserum : results from an IFCC multicenter study. Clin Chem LabMed, 2010,48:1593-1601.
  • 4Schumann G, Bonora R, Ceriotti F, et al. IFCC primaryreference procedures for the measurement of catalytic activityconcentrations of enzymes at 37 °C . Part 5. Reference procedurefor the measurement of catalytic concentration of aspartateaminotransferase. Clin Chem Lab Med, 2002,40:725-733.
  • 5Schumann G, Bonora R, Ceriotti F, et al. IFCC primaryreference procedures for the measurement of catalytic activityconcentrations of enzymes at 37 °C . Part 4. Reference procedurefor the measurement of catalytic concentration of alanineaminotransferase. Clin Chem Lab Med, 2002,40:718-724.
  • 6Ruhl CE, Everhart JE. Upper limits of normal for Alanineaminotransferase activity in the United States Population.Hepatology, 2012, 55 :447-454.
  • 7Schumann G,Klauke R, Canalias F, et al. IFCC primaryreference procedures for the measurement of catalytic activityconcentrations of enzymes at 37 X.. Part 9. reference procedurefor the measurement of catalytic concentration of alkalinephosphatase. Clin Chem Lab Med, 2011,49: 1439-1446.
  • 8College of American Pathologists. Alkaline phosphataseChemistrysurvey 1997. Northfield, IL: College of American Pathologists,1997, 7:11-14.
  • 9Schumann G, Bonora R, Ceriotti F, et al. IFCC primaryreference procedures for the measurement of catalytic activityconcentrations of enzymes at 37 X.. Part 6. Reference procedurefor the measurement of catalytic concentration of gamma-glutamyltransferase. Clin Chem Lab Med, 2002,40:734-738.
  • 10Banderasa DZ, Escobedoa J,Gonzalezb E, et al. -y-Glutamyltransferase : a marker of nonalcoholic fatty liver disease in patientswith the metabolic syndrome. Eur J Gastroenterol Hepatol, 2012 ,24:805-810.

二级参考文献13

  • 1樊嘉,周俭,徐泱,邱双健,吴志全,余耀,黄晓武,汤钊猷,王玉琦.肝癌肝移植适应证的选择:上海复旦标准[J].中华医学杂志,2006,86(18):1227-1231. 被引量:121
  • 2Omata M, Lesmana LA, Tateishi R, et al. Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma[J]. Hepatol Int, 2010, 4(2):439-474.
  • 3Breedis C, Young G. The blood supply of neoplasm in the liver[J]. Am J Pathol, 1954, 30(5):969-977.
  • 4Zheng SS, Xu X, Wu J, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences[J]. Transplantation, 2008, 85(12): 1726-1732.
  • 5Printz C. Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM)[J]. Cancer, 2009, 115(20):4646.
  • 6Tang ZY, Ye SL, Liu YK, et al. A decade's studies on metastasis of hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2004, 130(4):187-196.
  • 7Bruix J, Sherman M. Management of hepatocellular carcinoma: An Update. Practice Guidelines Committee, American Association for the Study of Liver Diseases[DB/OL]. 2010, http://www.aasld.org.
  • 8Bruix J, Sherman M. Management of hepatocellular carcinoma. Practice guidelines committee, American association for the study of liver diseases[J]. Hepatology, 2005, 42(5):1208-1236.
  • 9Giannini E,Botta F, Fasoli A, et al. Progressive liver functional impairment is associated with an increase in AST/ALT ratio[J].Dig Dis Sci, 1999;44(6): 1249-1253.
  • 10杨秉辉,丛文铭,周晓军,陈孝平,杨甲梅,樊嘉,王建华,杨仁杰,李槐,蒋国梁,曾昭冲,陈敏华,陈敏山,梁萍,吕明德,罗荣城,刘鲁明,秦叔逵,叶胜龙,吴孟超,汤钊猷,孙燕,管忠震.原发性肝癌规范化诊治专家共识[J].临床肿瘤学杂志,2009,14(3):259-269. 被引量:310

共引文献163

同被引文献107

引证文献17

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部